An prosthetic heart valve is a device implanted in the heart of a patient with valvular heart disease. When one of the four heart valves malfunctions, the medical choice may be to replace the natural valve with an artificial valve. This requires open-heart surgery.
Due to the COVID-19 pandemic, the global Prosthetic Heart Valves market size is estimated to be worth US$ 6609.4 million in 2021 and is forecast to a readjusted size of US$ 10500 million by 2028 with a CAGR of 6.7% during the forecast period 2022-2028. Fully considering the economic change by this health crisis, the Europe Prosthetic Heart Valves market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while Chinese percentage is %, and it is predicted that China market share will reach % in 2028, trailing a CAGR of % through the analysis period. As for the Europe Prosthetic Heart Valves landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.
In 2018, North America is expected to dominate the prosthetic heart valve market, followed by Europe, Asia-Pacific, and the RoW. North America is also expected to register the highest CAGR during the forecast period. The large share and high growth in this regional segment can be attributed to factors such as the rapid growth in the aging population and prevalence of valvular heart diseases, favorable reimbursement scenario, and rising product approvals for heart valves are contributing to the growth of the North American prosthetic heart valve market.
This report focuses on Prosthetic Heart Valves volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall Prosthetic Heart Valves market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan, etc.
Global Prosthetic Heart Valves Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Transcatheter Heart Valves
Tissue Heart Valves
Mechanical Heart Valves
Segment by Application
Hospitals
Ambulatory Surgery Centres
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
By Company
Edwards Lifesciences
Boston Scientific
Abbott Laboratories
Abbott
Medtronic
SYMETIS
LivaNova
CryoLife, Inc
Braile Biomedica
Colibri Heart Valve
JenaValve Technology
Lepu Medical Technology